NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Outcomes4Me

Outcomes4Me

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://outcomes4me.com/

Last Round

Series A

May 29, 2025

Total Funding Raised

$37.7M

Company Overview

Outcomes4Me is a healthtech company that provides an AI-driven, direct-to-patient platform for cancer care, offering personalized treatment options, clinical trial matching, and symptom management.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

clinical trial matchingcancer navigationreal-world evidenceRWEpatient engagementdigital healthhealth techelectronic health recordEHRclinical guidelinespatient recruitmentdata as a serviceDaaSgenomic datacancer care app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Outcomes4Me Comparables

Compare Outcomes4Me with similar companies based on industry and business-model similarity.

Outcomes4Me comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Belong.Life
81%
Jasper Health
78%
OncoPower
77%

Outcomes4Me Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 29, 2025
Series AApr 28, 2021
SeedNov 18, 2020

Key People

Founding team and executive leadership

Michael Sheeley

Chief Product Officer

Executive Team

Outcomes4Me Investors

Notable investors and investment history

Outcomes4Me investors
InvestorRounds
National Cancer InstituteSeed
Sierra VenturesSeries A, Seed
Salica InvestmentsSeries A
Salica InvestmentsSeries A
Asset Management VenturesSeries A, Seed
Northpond VenturesSeries A
Hambro Perks Ltd.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 10, 2025

    Launched a cancer-focused app incorporating NCCN guidelines.

  • Oct 9, 2025

    Named to TIME's list of the Best Inventions of 2025.

Outcomes4Me Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Outcomes4Me Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Outcomes4Me's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range32
Year Founded2017
Last FundingMay 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.